Drug Enforcement Administration 2013 – Federal Register Recent Federal Regulation Documents

Thomas Neuschatz, M.D.; Decision and Order
Document Number: 2013-29956
Type: Notice
Date: 2013-12-17
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Perampanel into Schedule III
Document Number: 2013-28778
Type: Rule
Date: 2013-12-02
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Deputy Administrator of the Drug Enforcement Administration (DEA) places the substance perampanel [2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl) benzonitrile], including its salts, isomers, and salts of isomers, into schedule III of the Controlled Substances Act (CSA). This scheduling action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule III controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities with, or possess) or propose to handle perampanel.
Zizhuang Li, M.D.; Decision and Order
Document Number: 2013-28525
Type: Notice
Date: 2013-11-29
Agency: Drug Enforcement Administration, Department of Justice
Wheatland Pharmacy; Decision and Order
Document Number: 2013-27700
Type: Notice
Date: 2013-11-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; GE Healthcare
Document Number: 2013-27661
Type: Notice
Date: 2013-11-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Mylan Pharmaceuticals, Inc.
Document Number: 2013-27660
Type: Notice
Date: 2013-11-19
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Morton Grove Pharmaceuticals
Document Number: 2013-27490
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Johnson Matthey, Inc.
Document Number: 2013-27488
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Apertus Pharmaceuticals
Document Number: 2013-27487
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration: AMPAC Fine Chemicals, LLC.
Document Number: 2013-27484
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Johnson Matthey, Inc.
Document Number: 2013-27483
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Catalent CTS, LLC
Document Number: 2013-27482
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Registration, Chattem Chemicals, Inc.
Document Number: 2013-27481
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Noramco, Inc.
Document Number: 2013-27457
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Cerilliant Corporation
Document Number: 2013-27454
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application: Johnson Matthey, Inc.
Document Number: 2013-27448
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Phenethylamines Into Schedule I
Document Number: 2013-27315
Type: Rule
Date: 2013-11-15
Agency: Drug Enforcement Administration, Department of Justice
The Deputy Administrator of the Drug Enforcement Administration (DEA) is issuing this final order to temporarily schedule three synthetic phenethylamines into the Controlled Substances Act (CSA) pursuant to the temporary scheduling provisions of 21 U.S.C. 811(h). The substances are 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5), 2-(4- chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82), and 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) [hereinafter 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe]. This action is based on a finding by the Deputy Administrator that the placement of these synthetic phenethylamines and their optical, positional, and geometric isomers, salts and salts of isomers in schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities, and possess), or propose to handle these synthetic phenethylamines.
Schedules of Controlled Substances: Placement of Tramadol Into Schedule IV
Document Number: 2013-25933
Type: Proposed Rule
Date: 2013-11-04
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes to place the substance 2-((dimethylamino)methyl)-1-(3- methoxyphenyl)cyclohexanol, its salts, isomers, salts of isomers, and all isomeric configurations of possible forms including tramadol (the term ``isomers'' includes the optical and geometric isomers) into Schedule IV of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Assistant Secretary for Health of the Department of Health and Human Services (HHS) and an evaluation of all other relevant data by the DEA. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to Schedule IV controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities, or possess) or propose to handle tramadol.
Manufacturer of Controlled Substances; Notice of Application; Cedarburg Pharmaceuticals, Inc.
Document Number: 2013-25102
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; GE Healthcare
Document Number: 2013-25101
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Registration, Siegfried USA, LLC
Document Number: 2013-25098
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, Stepan Company
Document Number: 2013-25097
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Boehringer Ingelheim Chemicals, Inc.
Document Number: 2013-25096
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Watson Pharma, Inc.
Document Number: 2013-25094
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Cambrex Charles City, Inc.
Document Number: 2013-25091
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Registration, Siegfried (USA), LLC
Document Number: 2013-25090
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Pharmacore, Inc.
Document Number: 2013-25088
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Stepan Company
Document Number: 2013-25087
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Registration, Boehringer Ingelheim Chemicals
Document Number: 2013-25086
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, Research Triangle Institute
Document Number: 2013-25085
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Registration, Penick Corporation
Document Number: 2013-25084
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Registration, Akorn, Inc.
Document Number: 2013-25081
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, Nektar Therapeutics
Document Number: 2013-25079
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Agilent Technologies
Document Number: 2013-25078
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Application, Wildlife Laboratories, Inc.
Document Number: 2013-25077
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Sigma Aldrich Research Biochemicals, Inc.
Document Number: 2013-25076
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Siegfried USA, LLC
Document Number: 2013-25075
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; United States Pharmacopeial Convention
Document Number: 2013-25073
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Registration, Austin Pharma, LLC.
Document Number: 2013-25072
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Noramco, Inc.
Document Number: 2013-25069
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Noramco, Inc. (GA)
Document Number: 2013-25067
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Penick Corporation
Document Number: 2013-25064
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Cambrex Charles City, Inc.
Document Number: 2013-25062
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Chemtos, LLC
Document Number: 2013-25060
Type: Notice
Date: 2013-10-25
Agency: Drug Enforcement Administration, Department of Justice
Ronald F. Lambert, D.D.S.; Decision and Order
Document Number: 2013-24698
Type: Notice
Date: 2013-10-22
Agency: Drug Enforcement Administration, Department of Justice
Mark G. Medinnus, D.D.S.; Decision and Order
Document Number: 2013-24697
Type: Notice
Date: 2013-10-22
Agency: Drug Enforcement Administration, Department of Justice
Morris W. Cochran, M.D.; Decision and Order
Document Number: 2013-24696
Type: Notice
Date: 2013-10-22
Agency: Drug Enforcement Administration, Department of Justice